Published in Mol Cancer Ther on February 01, 2007
Collagen XIX is expressed by interneurons and contributes to the formation of hippocampal synapses. J Comp Neurol (2010) 1.02
MMP generated matrikines. Matrix Biol (2015) 0.99
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. Biochim Biophys Acta (2015) 0.84
Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment. Invest Ophthalmol Vis Sci (2013) 0.81
The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction. Oncotarget (2016) 0.78
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX. Oncotarget (2015) 0.78
Collagen-derived matricryptins promote inhibitory nerve terminal formation in the developing neocortex. J Cell Biol (2016) 0.76
Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature. Clin Cosmet Investig Dermatol (2016) 0.75
Pleural effusion in a patient with multiple myeloma. Clin Chem (2012) 2.52
Active Coxsackieviral B infection is associated with disruption of dystrophin in endomyocardial tissue of patients who died suddenly of acute myocardial infarction. J Am Coll Cardiol (2007) 2.42
Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells. Anal Biochem (2004) 1.65
Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis. Eur Heart J (2009) 1.45
The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res (2004) 1.18
[Cutaneous and bone metastases revealing hepatocarcinoma]. Gastroenterol Clin Biol (2005) 1.11
Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol (2002) 1.10
Control of melanoma cell invasion by type IV collagen. Cancer Detect Prev (2004) 1.03
Lumican inhibits angiogenesis by interfering with α2β1 receptor activity and downregulating MMP-14 expression. Thromb Res (2011) 1.03
Highly stable fluorescent nanocrystals as a novel class of labels for immunohistochemical analysis of paraffin-embedded tissue sections. Lab Invest (2002) 1.01
An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. Crit Rev Oncol Hematol (2004) 1.00
Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes. Cancer Lett (2009) 0.98
Identification of beta1 integrin as mediator of melanoma cell adhesion to lumican. Biochem Biophys Res Commun (2007) 0.98
Lumican inhibits cell migration through α2β1 integrin. Exp Cell Res (2010) 0.96
Oriented conjugates of single-domain antibodies and quantum dots: toward a new generation of ultrasmall diagnostic nanoprobes. Nanomedicine (2011) 0.96
Control of melanoma progression by various matrikines from basement membrane macromolecules. Crit Rev Oncol Hematol (2004) 0.96
The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration. Int J Cancer (2010) 0.95
Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma? Am J Surg Pathol (2007) 0.93
Human collagen Krox up-regulates type I collagen expression in normal and scleroderma fibroblasts through interaction with Sp1 and Sp3 transcription factors. J Biol Chem (2007) 0.93
Chondroitin sulfate proteoglycans in tumor progression. Adv Pharmacol (2006) 0.92
In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model. Exp Cell Res (2004) 0.92
Brain tissue characterisation by infrared imaging in a rat glioma model. Biochim Biophys Acta (2006) 0.90
Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14. PLoS One (2012) 0.89
Specific protein-1 is a universal regulator of UDP-glucose dehydrogenase expression: its positive involvement in transforming growth factor-beta signaling and inhibition in hypoxia. J Biol Chem (2003) 0.89
Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system. Exp Cell Res (2003) 0.89
Functionalized nanocrystal-tagged fluorescent polymer beads: synthesis, physicochemical characterization, and immunolabeling application. Anal Biochem (2004) 0.88
Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med (2005) 0.88
The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent. J Biol Chem (2003) 0.87
Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation. Biochim Biophys Acta (2008) 0.87
Lumican affects actin cytoskeletal organization in human melanoma A375 cells. Life Sci (2008) 0.86
Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine. PLoS One (2012) 0.85
Discriminating healthy from tumor and necrosis tissue in rat brain tissue samples by Raman spectral imaging. Biochim Biophys Acta (2007) 0.85
Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins. FEBS J (2013) 0.84
Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas. Hum Pathol (2004) 0.84
Downregulation of BRCA1 in A375 melanoma cell line increases radio-sensitivity and modifies metastatic and angiogenic gene expression. J Invest Dermatol (2004) 0.82
Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R. J Alzheimers Dis (2013) 0.82
Semiconductor quantum dots for multiplexed bio-detection on solid-state microarrays. Crit Rev Oncol Hematol (2009) 0.81
Topotecan-induced alterations in the amount and stability of human DNA topoisomerase I in solid tumor cell lines. Anticancer Res (2004) 0.81
Modeling and quantifying biochemical changes in C6 tumor gliomas by Fourier transform infrared imaging. Anal Chem (2008) 0.81
Structural and antitumor properties of the YSNSG cyclopeptide derived from tumstatin. Chem Biol (2006) 0.81
Preliminary investigation of a mice model of Klebsiella pneumoniae subsp. ozaenae induced pneumonia. Microbes Infect (2011) 0.81
Self-assembly of charged microclusters of CdSe/ZnS core/shell nanodots and nanorods into hierarchically ordered colloidal arrays. Nanotechnology (2006) 0.80
Emerging applications of fluorescent nanocrystals quantum dots for micrometastases detection. Proteomics (2010) 0.80
Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts. Mol Cell Biochem (2005) 0.80
Efficacy of ω-3 polyunsaturated fatty acids for the treatment of refractory hydroa vacciniforme. Pediatr Dermatol (2011) 0.79
Interaction of clinically important human DNA topoisomerase I poison, topotecan, with double-stranded DNA. Biopolymers (2003) 0.78
A crucial role for Lyn in TIMP-1 erythroid cell survival signalling pathway. FEBS Lett (2013) 0.78
Malondialdehyde binding to proteins dramatically alters fibroblast functions. J Cell Physiol (2002) 0.78
Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration. FEBS Lett (2009) 0.78
Ultraviolet-B irradiation induces epidermal up-regulation of heparanase expression and activity. J Photochem Photobiol B (2011) 0.78
Changes of skin collagen orientation associated with chronological aging as probed by polarized-FTIR micro-imaging. Analyst (2014) 0.78
Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer. Anticancer Res (2007) 0.78
c-Krox down-regulates the expression of UDP-glucose dehydrogenase in chondrocytes. Biochem Biophys Res Commun (2005) 0.78
FTIR protein secondary structure analysis of human ascending aortic tissues. J Biophotonics (2008) 0.78
Deletion 2q36.2q36.3 with multiple renal cysts and severe mental retardation. Eur J Med Genet (2008) 0.78
A new anti-tumor strategy based on in vivo tumstatin overexpression after plasmid electrotransfer in muscle. Biochem Biophys Res Commun (2013) 0.77
The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells. Mol Carcinog (2013) 0.77
Lumican - derived peptides inhibit melanoma cell growth and migration. PLoS One (2013) 0.77
The NC1 domain of type XIX collagen inhibits melanoma cell migration. Eur J Dermatol (2010) 0.77
Rapid characterization of glycosaminoglycans using a combined approach by infrared and Raman microspectroscopies. J Pharm Sci (2011) 0.77
[Comparative analysis of immunoglobulin free light chains quantification by Freelite™ (The Binding Site) and N Latex FLC (Siemens) methods]. Ann Biol Clin (Paris) (2013) 0.77
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent. Invest New Drugs (2014) 0.77
Investigating the relationship between changes in collagen fiber orientation during skin aging and collagen/water interactions by polarized-FTIR microimaging. Analyst (2015) 0.76
Characterization of glycosaminoglycans by tandem vibrational microspectroscopy and multivariate data analysis. Methods Mol Biol (2012) 0.75
Glycosaminoglycan profiling in different cell types using infrared spectroscopy and imaging. Anal Bioanal Chem (2014) 0.75
[Diagnostic value of clinical signs in giant cell arteritis: analysis of 415 temporal artery biopsy findings]. Ann Med Interne (Paris) (2002) 0.75
[Proteolysis directed by the extracellular matrix]. J Soc Biol (2003) 0.75
[Autopsy room and the July 30th 2004 memorandum]. Ann Pathol (2005) 0.75
[Biological effects of collagen I and IV peptides]. J Soc Biol (2003) 0.75
Non-covalent complexes between bis-beta-carbolines and double-stranded DNA: A study by electrospray ionization FT-ICR mass spectrometry (I). Bioorg Med Chem Lett (2007) 0.75
[Recommendations for the management of monoclonal gammopathies in biochemistry]. Ann Biol Clin (Paris) (2012) 0.75
Camptothecin conjugated with DNA minor-groove binder netropsin: enhanced lactone stability, inhibition of human DNA topoisomerase I and antiproliferative activity. Anticancer Res (2003) 0.75
Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia. Asian Pac J Cancer Prev (2016) 0.75
[Metastasis and pulmonary pseudo-tumors]. Ann Pathol (2004) 0.75
[Increased plasma C-reactive protein in a pregnant woman with multiple sclerosis: corticotherapy or not ?]. Ann Biol Clin (Paris) (2010) 0.75
[Matrikines: a new anticancer therapeutic strategy]. Biol Aujourdhui (2012) 0.75